These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 15642672)

  • 1. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
    Schwartz J; Leber MD; Gillis S; Giunta A; Eldor A; Bussel JB
    Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
    Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S
    J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
    Zoghlami-Rintelen C; Weltermann A; Bittermann C; Kyrle PA; Pabinger I; Lechner K; Wenzl E
    Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
    Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
    Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution.
    Zheng CX; Zheng D; Chen LH; Yu JF; Wu ZM
    Chin Med J (Engl); 2011 Apr; 124(8):1175-80. PubMed ID: 21542991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
    Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
    Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A
    Platelets; 2011; 22(1):1-7. PubMed ID: 20964585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
    Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
    Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M
    Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
    Duperier T; Brody F; Felsher J; Walsh RM; Rosen M; Ponsky J
    Arch Surg; 2004 Jan; 139(1):61-6; discussion 66. PubMed ID: 14718278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy for adult chronic idiopathic thrombocytopenic purpura: experience from a single center in China.
    Wang T; Xu M; Ji L; Han ZC; Yang R
    Eur J Haematol; 2005 Nov; 75(5):424-9. PubMed ID: 16191093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)?
    Tsereteli Z; Smith CD; Branum GD; Galloway JR; Amerson RJ; Chakaraborty H; Hunter JG
    Surg Endosc; 2001 Dec; 15(12):1386-9. PubMed ID: 11965451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.